Skip to content

8-KAccepted Oct 13, 8:35 AM ET

MetaVia Inc.: appoints chief medical officer

MTVAMetaVia Inc.

Accepted (ET)

8:35 AM

Oct 13, 2026

Filed

Oct 13, 2026

Documents

14

Size

420.8 KB

Summary

MetaVia Inc.: appoints chief medical officer

Updated

What happened MetaVia Inc announced the appointment of Sarah Kaplan Browne, M.D. as chief medical officer, effective Oct 12, 2026. The company issued a press release on Oct 13, 2026, reporting the appointment.

Key details

  • Appointee: Sarah Kaplan Browne, M.D.
  • Effective date: Oct 12, 2026.
  • Press release issued: Oct 13, 2026.
  • Form 8-K signed by Hyung Heon Kim, president and chief executive officer, dated Oct 13, 2026.

Why it may matter The filing reports Item 7.01 (Regulation FD Disclosure) — disclosure via a press release — and Item 8.01 (Other Events) — the appointment of an officer effective Oct 12, 2026. A filing does not show why the insider traded or why the company acted.

AI-written summary · check the filing